Molsys

Bengaluru, India Founded: 2017 • Age: 9 yrs
Provides cloud-based bioinformatics services for advanced data analysis and solutions.
Annual revenue $125,425 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Molsys

Molsys is a company based in Bengaluru (India) founded in 2017 by Anupam Das and Gaurab Banerjee. It operates as a B2B. Molsys operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.

  • Headquarter Bengaluru, India
  • Founders Anupam Das, Gaurab Banerjee
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Molsys Private Limited
  • Date of Incorporation 22 Jun, 2018
  • Jurisdiction Bengaluru, Karnataka, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $125.43 K (USD)
    22.07
    as on Mar 31, 2022
  • Net Profit
    $7.28 K (USD)
    165.46
    as on Mar 31, 2022
  • EBITDA
    $5.4 K (USD)
    344.5
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Molsys

Premium access

Detailed funding history for Molsys

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Molsys

Investments
Premium access

Investment portfolio details for Molsys

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Molsys

Premium access

Detailed financials for Molsys

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Molsys Comparisons

Molsys Primary company
Description
Provides cloud-based bioinformatics services for advanced da...
Location
Bengaluru, India
Founded Year
2017
Annual Revenue
$125.43 K (USD)
Net Profit
$7.28 K (USD)
EBITDA
$5.4 K (USD)
Employees
Not available
Premium access

Peer comparison for Molsys

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Molsys

Molsys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genomic services and solutions with NGS expertise are provided.
Locked Locked Locked
Gene-editing platform and anti-aging therapy for dogs are developed.
Locked Locked Locked
Multiple genomic services are provided for analysis and diagnostics.
Locked Locked Locked
NGS-based diagnostic solutions for neonatal screening are developed.
Locked Locked Locked
Next-generation sequencing and genomics services are provided globally.
Locked Locked Locked
Genome sequencing, analysis, and genetic screening services are provided.
Premium access

Detailed competitors of Molsys

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Molsys

Premium access

Complete news archive for Molsys

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Molsys

Molsys was founded in 2017.

Molsys is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Annual revenue of Molsys is $125.43K as on Mar 31, 2022.

Molsys operates with a B2B model, focusing on leveraging cutting-edge technology, bioinformatics, providing cloud services, and bioinformatic tools. Provides cloud-based bioinformatics services for advanced data analysis and solutions. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Molsys's top competitors include Novogene Corporation, Source BioScience and Genewiz.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available